RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
G
Apob
apolipoprotein B
ISO
protein:increased expression:serum
RGD
PMID:18076041
RGD:2325763
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:30,844,368...30,892,497
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
DNA:polymorphism:exon:rs2606345 (human)
RGD
PMID:19168589
RGD:2317210
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Ppard
peroxisome proliferator-activated receptor delta
ISO
RGD
PMID:18497548
RGD:2324871
NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,298,785...6,363,968
G
Ddr2
discoidin domain receptor tyrosine kinase 2
disease_progression
ISO
RGD
PMID:29043607
RGD:150429712
NCBI chr13:84,726,412...84,851,032
Ensembl chr13:82,195,463...82,317,363
G
Ifitm1
interferon induced transmembrane protein 1
disease_progression
ISO
RGD
PMID:29043607
RGD:150429712
NCBI chr 1:205,496,757...205,498,796
Ensembl chr 1:196,067,963...196,069,169
G
Slc7a5
solute carrier family 7 member 5
disease_progression
ISO
RGD
PMID:24131658
RGD:151361287
NCBI chr19:66,843,808...66,872,412
Ensembl chr19:49,935,220...49,963,823
G
Apob
apolipoprotein B
susceptibility
ISO
DNA:polymorphisms:intron, exon:IVS6+360C>T, 56C>T (human)
RGD
PMID:18296645
RGD:2317550
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:30,844,368...30,892,497
G
Apoe
apolipoprotein E
susceptibility
ISO
DNA:SNP:intron:rs440446 (human)
RGD
PMID:18296645
RGD:2317550
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
Atm
ATM serine/threonine kinase
ISO
ClinVar Annotator: match by term: Bile duct cancer
ClinVar
PMID:9887333 PMID:17124347 PMID:20077034 PMID:25741868 PMID:26635394 PMID:28492532 More...
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:53,831,093...53,932,437
G
Mir31
microRNA 31
exacerbates
ISO
RNA:increased expression:bile duct (human)
RGD
PMID:29860474
RGD:152998990
NCBI chr 5:108,714,849...108,714,954
G
Mlh1
mutL homolog 1
ISO
ClinVar Annotator: match by term: Bile duct cancer
ClinVar
PMID:15340264 PMID:17510385 PMID:18307539 PMID:19419416 PMID:22136435 PMID:22703879 PMID:24033266 PMID:24728327 PMID:25741868 PMID:28492532 More...
NCBI chr 8:120,074,871...120,112,109
Ensembl chr 8:111,196,468...111,233,617
G
Msh2
mutS homolog 2
ISO
ClinVar Annotator: match by term: Bile duct cancer
ClinVar
PMID:25741868 PMID:33357406
NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:6,813,795...6,872,938
G
Palb2
partner and localizer of BRCA2
ISO
ClinVar Annotator: match by term: Bile duct cancer
ClinVar
PMID:25741868 PMID:26467025 PMID:28492532 PMID:30287823
NCBI chr 1:186,096,312...186,120,284
Ensembl chr 1:176,665,076...176,688,990
G
Pkd1
polycystin 1, transient receptor potential channel interacting
ISO
ClinVar Annotator: match by term: Bile duct cancer
ClinVar
PMID:12007219 PMID:16430766 PMID:17574468 PMID:25741868 PMID:26467025 PMID:27782177 More...
NCBI chr10:14,077,733...14,125,682
Ensembl chr10:13,573,021...13,621,128
G
Pold1
DNA polymerase delta 1, catalytic subunit
ISO
ClinVar Annotator: match by term: Bile duct cancer
ClinVar
PMID:25741868 PMID:26467025 PMID:28492532
NCBI chr 1:104,161,984...104,178,074
Ensembl chr 1:95,025,499...95,036,465
G
Stk11
serine/threonine kinase 11
ISO
ClinVar Annotator: match by term: Bile duct cancer
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 7:10,225,204...10,241,965
Ensembl chr 7:9,575,269...9,591,315
G
Tjp1
tight junction protein 1
ISO
protein:decreased expression:bile duct
RGD
PMID:19184677
RGD:2325030
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:118,849,838...119,094,432
G
Msln
mesothelin
ISO
protein:increased expression:bile duct
RGD
PMID:17276942
RGD:2326059
NCBI chr10:14,771,946...14,781,382
Ensembl chr10:14,771,961...14,777,643
G
Slc7a5
solute carrier family 7 member 5
disease_progression
ISO
RGD
PMID:24890221
RGD:151361210
NCBI chr19:66,843,808...66,872,412
Ensembl chr19:49,935,220...49,963,823
G
Abcc2
ATP binding cassette subfamily C member 2
susceptibility
ISO
DNA:polymorphism:exon:c.3972C>T (human)
RGD
PMID:19451719
RGD:2317508
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238
G
Adrb2
adrenoceptor beta 2
ISO
protein:decreased expression:liver
RGD
PMID:16292515
RGD:2325640
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:55,502,903...55,644,512
G
Alb
albumin
disease_progression
ISO
RGD
PMID:10776430 PMID:20431764 PMID:17545000
RGD:2325682 , RGD:2325679 , RGD:2325680
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Alox5
arachidonate 5-lipoxygenase
ISO
protein:increased expression:bile duct
RGD
PMID:18507031
RGD:2317521
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:149,531,515...149,578,743
G
Anxa2
annexin A2
disease_progression
ISO
RGD
PMID:20493868
RGD:2325728
NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:70,105,253...70,141,658
G
Anxa8
annexin A8
ISO
RGD
PMID:19376120
RGD:2325733
NCBI chr16:9,403,267...9,418,317
Ensembl chr16:9,397,113...9,412,043
G
Apc
APC regulator of WNT signaling pathway
ISO
DNA:hypermethylation:promoter DNA:loss of heterozygosity
RGD
PMID:15467712 PMID:10212000
RGD:2317198 , RGD:2317205
NCBI chr18:26,138,382...26,196,021
Ensembl chr18:25,864,222...25,922,696
G
Apoa1
apolipoprotein A1
ISO
protein:decreased expression:serum
RGD
PMID:19486127
RGD:2325756
NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:46,527,144...46,529,035
G
Arid1a
AT-rich interaction domain 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24185509
NCBI chr 5:151,192,014...151,269,291
Ensembl chr 5:145,908,181...145,985,564
G
Asph
aspartate-beta-hydroxylase
ISO
RGD
PMID:21898484
RGD:6902945
NCBI chr 5:27,398,933...27,611,519
Ensembl chr 5:22,603,486...22,813,876
G
Atg101
autophagy related 101
disease_progression
ISO
RGD
PMID:35592424
RGD:153350091
NCBI chr 7:132,398,477...132,407,643
Ensembl chr 7:132,398,483...132,407,633
G
Bap1
BRCA1 associated deubiquitinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24185509 PMID:25231345
NCBI chr16:6,453,126...6,461,952
Ensembl chr16:6,446,709...6,455,535
G
Birc6
baculoviral IAP repeat-containing 6
ameliorates
ISO
mRNA:increased expression:bile duct (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr 6:26,474,843...26,668,275
Ensembl chr 6:20,722,922...20,916,434
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
IAGP
DNA:missense mutation:cds:p.V600E (human)
RGD
PMID:12692057
RGD:11073239
NCBI chr 4:69,329,772...69,476,931
Ensembl chr 4:68,384,649...68,510,463
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
onset
ISO
protein:decreased expression:liver
RGD
PMID:15619210
RGD:2317417
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:103,984,949...104,003,149
G
Cxcr1
C-X-C motif chemokine receptor 1
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:18550579
NCBI chr 9:83,216,040...83,220,225
Ensembl chr 9:75,766,770...75,771,084
G
Cycs
cytochrome c, somatic
ISO
RGD
PMID:19788692
RGD:2317615
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Cyp24a1
cytochrome P450, family 24, subfamily a, polypeptide 1
ISO
protein:increased expression:intrahepatic bile, extrahepatic bile duct (human)
RGD
PMID:23375797
RGD:151361187
NCBI chr 3:179,694,647...179,709,083
Ensembl chr 3:159,275,947...159,290,383
G
Egf
epidermal growth factor
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:18550579 PMID:25741868 PMID:28492532
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:218,219,415...218,302,064
G
Egfr
epidermal growth factor receptor
ISO
CTD Direct Evidence: therapeutic ClinVar Annotator: match by term: Cholangiocarcinoma
CTD ClinVar
PMID:17341899 PMID:18550579 PMID:24728327 PMID:25741868 PMID:28492532
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
G
Epo
erythropoietin
IEP
mRNA, protein:increased expression:liver
RGD
PMID:23052842
RGD:10400912
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:19,204,508...19,207,946
G
Epor
erythropoietin receptor
IEP
mRNA, protein:increased expression:liver
RGD
PMID:23052842
RGD:10400912
NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:20,489,678...20,494,257
G
Erbb2
erb-b2 receptor tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16818635
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,411,313...83,435,078
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
disease_progression no_association
ISO
DNA:SNP: :g.148505302C>T (rs887569) (human) DNA:SNPs: :g.148525904C>G, (rs2302427), g.148519011C>T (rs6464926), g.148517456T>G (rs17171119) (human)
RGD
PMID:24179546 PMID:24179546
RGD:126779604 , RGD:126779604
NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:76,624,399...76,687,362
G
Faslg
Fas ligand
ISO
RGD
PMID:11029528
RGD:2317746
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:74,154,954...74,162,215
G
Fgf2
fibroblast growth factor 2
ISO
protein:increased expression:bile
RGD
PMID:11478488
RGD:2317765
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
G
Fgfr2
fibroblast growth factor receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26258846
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:184,745,420...184,850,626
G
Fscn1
fascin actin-bundling protein 1
disease_progression
ISO
protein:increased expression:bile ducts
RGD
PMID:19721413
RGD:2317780
NCBI chr12:16,710,601...16,723,734
Ensembl chr12:11,597,048...11,610,211
G
Gnas
GNAS complex locus
disease_progression
ISO
DNA:polymorphism:393T>C (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22561520 PMID:17356712
RGD:1601377
NCBI chr 3:183,489,648...183,554,570
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
G
Gstm1
glutathione S-transferase mu 1
ISO
RGD
PMID:24049014
RGD:14700980
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Gstp1
glutathione S-transferase pi 1
treatment
ISO
DNA:hypermethylation:promoter human cell line in a mouse model
RGD
PMID:15467712 PMID:12805482
RGD:2317198 , RGD:14401711
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Hdac6
histone deacetylase 6
ISO
protein:increased expression:liver:
RGD
PMID:23370327
RGD:9681560
NCBI chr X:17,222,538...17,244,373
Ensembl chr X:14,551,044...14,572,441
G
Hgf
hepatocyte growth factor
IEP ISO
mRNA, protein:increased expression: : protein:increased expression:serum
RGD
PMID:10827151 PMID:16974053
RGD:2317925 , RGD:2317909
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:18,677,101...18,745,409
G
Hif1a
hypoxia inducible factor 1 subunit alpha
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:12919954 PMID:18550579 PMID:22647679 PMID:24120591 PMID:25741868
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Idh1
isocitrate dehydrogenase (NADP(+)) 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24185509
NCBI chr 9:74,027,887...74,057,442
Ensembl chr 9:66,534,146...66,563,708
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24185509
NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:134,029,772...134,058,025
G
Il10
interleukin 10
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:25741868 PMID:28492532 More...
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il19
interleukin 19
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:25741868 PMID:28492532 More...
NCBI chr13:44,949,989...44,958,714
Ensembl chr13:42,399,138...42,405,473
G
Il1b
interleukin 1 beta
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:18550579
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1r2
interleukin 1 receptor type 2
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr 9:49,879,928...49,920,374
Ensembl chr 9:42,384,433...42,424,725
G
Il4r
interleukin 4 receptor
ISO
mRNA:increased expression:bile duct
RGD
PMID:18798553
RGD:2317263
NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:180,115,120...180,139,980
G
Il6
interleukin 6
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma protein:increased expression:serum CTD Direct Evidence: marker/mechanism
ClinVar CTD RGD
PMID:9769329 PMID:10720087 PMID:11001912 PMID:11889177 PMID:12519862 PMID:12560873 PMID:12719374 PMID:15070960 PMID:15331795 PMID:15472205 PMID:16150725 PMID:16278864 PMID:17621267 PMID:17623760 PMID:18550579 PMID:15011822 PMID:28925763 More...
RGD:2317167 , RGD:14975292
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Ins2
insulin 2
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:197,843,281...197,864,775
G
Kcnd2
potassium voltage-gated channel subfamily D member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34418280
NCBI chr 4:50,741,595...51,243,540
Ensembl chr 4:49,776,246...50,277,728
G
Kit
KIT proto-oncogene receptor tyrosine kinase
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,548,877...32,624,652
G
Kmt2c
lysine methyltransferase 2C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561520
NCBI chr 4:10,353,698...10,755,965
Ensembl chr 4:9,609,627...9,833,539
G
Kras
KRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8968066 PMID:22561520
NCBI chr 4:179,916,255...179,949,613
G
Krt7
keratin 7
ISO
RGD
PMID:18393293
RGD:2317308
NCBI chr 7:134,407,626...134,423,787
Ensembl chr 7:132,528,895...132,545,052
G
Mdm2
MDM2 proto-oncogene
disease_progression
ISO
protein:increased expression:intrahepatic bile duct (human)
RGD
PMID:15619210
RGD:2317417
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:53,290,664...53,314,915
G
Met
MET proto-oncogene, receptor tyrosine kinase
disease_progression
IEP ISO
protein:increased expression:liver, biliary epithelium (rat) protein:increased phosphorylation:liver, carcinoma (human)
RGD
PMID:14656942 PMID:16818635
RGD:2317601 , RGD:2317578
NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:45,790,791...45,897,876
G
Mfsd4a
major facilitator superfamily domain containing 4A
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr13:43,469,488...43,510,467
Ensembl chr13:43,469,488...43,510,467
G
Mgmt
O-6-methylguanine-DNA methyltransferase
ISO
DNA:hypermethylation:promoter (human)
RGD
PMID:17550320
RGD:2317632
NCBI chr 1:201,140,832...201,367,481
Ensembl chr 1:191,710,930...191,937,756
G
Mir155
microRNA 155
ISO
miRNA:increased expression:serum
RGD
PMID:30653586
RGD:21081530
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:23,774,654...23,774,718
G
Mir192
microRNA 192
ISO
RNA:increased expression:urine
RGD
PMID:26456596
RGD:41404678
NCBI chr 1:203,564,946...203,565,055
Ensembl chr 1:203,564,946...203,565,055
G
Mir21
microRNA 21
ISO
RNA:increased expression:urine
RGD
PMID:26456596
RGD:41404678
NCBI chr10:71,902,600...71,902,691
Ensembl chr10:71,405,257...71,405,348
G
Mir23b
microRNA 23b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34418280
NCBI chr17:1,819,386...1,819,482
Ensembl chr17:1,813,667...1,813,763
G
Mir494
microRNA 494
severity exacerbates
ISO
RGD
PMID:30314946 PMID:30314946
RGD:156420141 , RGD:156420141
NCBI chr 6:134,550,115...134,550,197
Ensembl chr 6:128,728,709...128,728,793
G
Mki67
marker of proliferation Ki-67
disease_progression
ISO
RGD
PMID:12903495
RGD:2317705
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762
G
Mmp2
matrix metallopeptidase 2
disease_progression
IEP ISO
protein:increased expression:bile duct
RGD
PMID:15213623 PMID:19629755
RGD:2324667 , RGD:2325769
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
ISO IEP
mRNA:increased expression:bile duct protein:increased expression:bile duct
RGD
PMID:16463672 PMID:15213623 PMID:15213623
RGD:2325856 , RGD:2324667 , RGD:2324667
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Msln
mesothelin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14576474
NCBI chr10:14,771,946...14,781,382
Ensembl chr10:14,771,961...14,777,643
G
Mthfr
methylenetetrahydrofolate reductase
susceptibility
ISO
DNA:polymorphism (human)
RGD
PMID:17201138
RGD:2317119
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:158,465,296...158,483,797
G
Muc1
mucin 1, cell surface associated
disease_progression
ISO IEP
protein:increased secretion:bile protein:increased expression:serum protein:increased expression:bile duct: mRNA:increased expression:bile duct
RGD
PMID:19055478 PMID:19260467 PMID:15213623 PMID:18081149 PMID:19639217
RGD:2324622 , RGD:2324664 , RGD:2324667 , RGD:2324638 , RGD:2317986
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:174,635,995...174,640,733
G
Muc16
mucin 16, cell surface associated
ISO
associated with Opisthorchiasis;protein:increased expression:serum
RGD
PMID:1653472
RGD:2325142
NCBI chr 8:24,440,840...24,644,494
G
Muc17
mucin 17, cell surface associated
ISO
mRNA:decreased expression:bile duct
RGD
PMID:11680592
RGD:2324948
NCBI chr12:25,139,076...25,175,249
Ensembl chr12:19,527,321...19,538,522
G
Muc2
mucin 2, oligomeric mucus/gel-forming
ISO
mRNA:decreased expression:bile duct
RGD
PMID:11680592
RGD:2324948
NCBI chr 1:206,225,775...206,261,280
Ensembl chr 1:196,799,517...196,831,756
G
Muc3a
mucin 3A, cell surface associated
ISO
mRNA:decreased expression:bile duct
RGD
PMID:11680592
RGD:2324948
NCBI chr12:19,450,679...19,454,753
Ensembl chr12:19,446,094...19,460,522
G
Muc4
mucin 4, cell surface associated
disease_progression
ISO IEP
protein:increased expression:bile duct
RGD
PMID:14752841 PMID:19082442
RGD:2324944 , RGD:2303602
NCBI chr11:81,513,321...81,575,200
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
disease_progression
ISO
protein:increased expression:serum mRNA:increased expression:bile duct
RGD
PMID:14508831 PMID:11680592
RGD:2324990 , RGD:2324948
NCBI chr 1:206,293,717...206,326,006
Ensembl chr 1:196,864,336...196,896,475
G
Muc5b
mucin 5B, oligomeric mucus/gel-forming
ISO
mRNA:decreased expression:bile duct
RGD
PMID:11680592
RGD:2324948
NCBI chr 1:196,916,861...196,948,830
Ensembl chr 1:196,916,825...196,949,250
G
Muc6
mucin 6, oligomeric mucus/gel-forming
ISO
protein:increased expression: :
RGD
PMID:10209489
RGD:2325167
NCBI chr 1:196,726,678...196,764,842
Ensembl chr 1:196,726,807...196,764,842
G
Nat2
N-acetyltransferase 2
ISO
DNA:polymorphisms (human)
RGD
PMID:15901993
RGD:2317172
NCBI chr16:26,974,874...27,005,191
Ensembl chr16:22,208,194...22,238,520
G
Ncam1
neural cell adhesion molecule 1
ISO
associated with hepatitis
RGD
PMID:12031086
RGD:2326079
NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:49,865,633...50,166,014
G
Nos2
nitric oxide synthase 2
ISO
protein:increased expression:bile duct CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16818635 PMID:16094703
RGD:2325280
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Notch1
notch receptor 1
ISO
protein:increased expression:cholangiocyte
RGD
PMID:15887117
RGD:2325330
NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:9,278,086...9,323,531
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
disease_progression
IEP
mRNA:decreased expression:liver (rat)
RGD
PMID:24255171
RGD:15090822
NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:23,846,122...23,942,047
G
Ogg1
8-oxoguanine DNA glycosylase
disease_progression
ISO
DNA:loss of heterozygosity (human)
RGD
PMID:11866974 PMID:11260864
RGD:2317134 , RGD:2317136
NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:146,474,750...146,484,766
G
Osbp2
oxysterol binding protein 2
ISO
mRNA:increased expression:blood
RGD
PMID:21763455
RGD:41404644
NCBI chr14:82,808,693...82,970,386
Ensembl chr14:78,585,089...78,746,786
G
Osbpl7
oxysterol binding protein-like 7
ISO
mRNA:increased expression:blood
RGD
PMID:21763455
RGD:41404644
NCBI chr10:82,035,995...82,053,566
Ensembl chr10:82,036,042...82,053,557
G
Panx2
pannexin 2
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr 7:122,018,937...122,032,009
Ensembl chr 7:120,139,294...120,152,361
G
Pawr
pro-apoptotic WT1 regulator
ISO
mRNA,protein:decreased expression:cholangiocyte:
RGD
PMID:20724592
RGD:9835357
NCBI chr 7:45,531,480...45,611,492
Ensembl chr 7:43,645,084...43,725,028
G
Pbrm1
polybromo 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24185509
NCBI chr16:6,213,507...6,312,895
Ensembl chr16:6,213,300...6,311,780
G
Peg3
paternally expressed 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561520
NCBI chr 1:67,097,874...67,124,692
Ensembl chr 1:67,097,904...67,124,671
G
Pes1
pescadillo ribosomal biogenesis factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34845814
NCBI chr14:78,850,754...78,867,134
Ensembl chr14:78,850,709...78,867,134
G
Pir
pirin
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr X:33,740,428...33,851,049
Ensembl chr X:30,108,538...30,219,218
G
Ppia
peptidylprolyl isomerase A
ameliorates
ISO
human cell line and construct in a mouse model
RGD
PMID:21871105
RGD:150429623
NCBI chr14:85,491,223...85,496,884
Ensembl chr14:81,275,091...81,299,601
G
Ppp3ca
protein phosphatase 3 catalytic subunit alpha
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr 2:227,839,058...228,113,560
Ensembl chr 2:225,165,766...225,438,974
G
Prex2
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2
sexual_dimorphism
ISO
DNA:substitutions, insertion/deletions: (human)
RGD
PMID:28000796
RGD:151665188
NCBI chr 5:12,720,683...13,036,077
Ensembl chr 5:7,942,573...8,253,068
G
Prkaca
protein kinase cAMP-activated catalytic subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26258846
NCBI chr19:41,059,843...41,083,189
Ensembl chr19:24,155,090...24,178,430
G
Prkacb
protein kinase cAMP-activated catalytic subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26258846
NCBI chr 2:238,297,140...238,389,317
Ensembl chr 2:235,636,885...235,726,198
G
Prrg4
proline rich and Gla domain 4
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr 3:91,214,646...91,243,347
Ensembl chr 3:91,214,653...91,243,273
G
Prss2
protease, serine, 2
ISO
protein:increased expression:serum
RGD
PMID:8621252
RGD:2324908
NCBI chr 4:70,278,304...70,283,385
Ensembl chr 4:70,278,304...70,283,385
G
Prss56
serine protease 56
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr 9:87,842,806...87,859,978
Ensembl chr 9:87,854,805...87,859,978
G
Pten
phosphatase and tensin homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27022031 PMID:23376645
RGD:12802341
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:230,630,338...230,696,838
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
protein:increased expression:bile duct ClinVar Annotator: match by term: Cholangiocarcinoma CTD Direct Evidence: marker/mechanism
ClinVar CTD RGD
PMID:16818635 PMID:19621664
RGD:2317180
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Rassf8
Ras association domain family member 8
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr 4:180,447,050...180,528,792
Ensembl chr 4:178,719,992...178,796,690
G
Reg1a
regenerating family member 1 alpha
susceptibility
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:11343228
RGD:10044031
NCBI chr 4:112,450,466...112,453,130
Ensembl chr 4:110,892,453...110,895,570
G
Rnf39
ring finger protein 39
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr20:1,610,027...1,615,516
Ensembl chr20:1,604,794...1,610,283
G
Rnf43
ring finger protein 43
exacerbates
ISO
CTD Direct Evidence: marker/mechanism associated with opisthorchiasis;DNA:SNPs:multiple: (human)
CTD RGD
PMID:22561520 PMID:22561520
RGD:151361227
NCBI chr10:72,958,744...73,034,540
Ensembl chr10:72,464,348...72,536,977
G
Robo2
roundabout guidance receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561520
NCBI chr11:26,015,919...27,583,750
Ensembl chr11:12,528,951...13,041,536
G
Runx3
RUNX family transcription factor 3
ISO
protein:decreased expression:bile duct
RGD
PMID:19827872
RGD:2324955
NCBI chr 5:152,644,270...152,702,835
Ensembl chr 5:147,360,994...147,419,156
G
Slc4a4
solute carrier family 4 member 4
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883
G
Slc5a5
solute carrier family 5 member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17408651
NCBI chr16:18,580,705...18,590,692
Ensembl chr16:18,546,709...18,556,697
G
Slc7a5
solute carrier family 7 member 5
disease_progression treatment
ISO
RGD
PMID:25475870 PMID:28347255 PMID:24131658
RGD:151361214 , RGD:151361294 , RGD:151361287
NCBI chr19:66,843,808...66,872,412
Ensembl chr19:49,935,220...49,963,823
G
Smad4
SMAD family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561520
NCBI chr18:69,518,988...69,549,684
Ensembl chr18:67,243,742...67,274,438
G
Socs3
suppressor of cytokine signaling 3
severity
ISO
protein:decreased expression:bile duct (human)
RGD
PMID:26485275
RGD:11250478
NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,193,537...103,197,787
G
Sox17
SRY-box transcription factor 17
severity
IEP
RGD
PMID:20816680
RGD:4889598
NCBI chr 5:19,814,345...19,819,859
Ensembl chr 5:15,016,731...15,022,228
G
Sox2
SRY-box transcription factor 2
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr 2:119,465,131...119,467,542
Ensembl chr 2:117,536,929...117,539,338
G
Tgfb1
transforming growth factor, beta 1
disease_progression
ISO IEP
protein:increased expression:pancreas
RGD
PMID:16083599 PMID:12632524
RGD:2325020 , RGD:1299231
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Tgfbr2
transforming growth factor, beta receptor 2
IEP
mRNA:increased expression:bile duct
RGD
PMID:12632524
RGD:1299231
NCBI chr 8:124,672,677...124,761,741
Ensembl chr 8:115,794,537...115,883,228
G
Thbs1
thrombospondin 1
disease_progression
ISO
DNA:hypermethylation (human)
RGD
PMID:11927969 PMID:12213730 PMID:16465407
RGD:2325027 , RGD:2325026 , RGD:2325024
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:105,056,292...105,071,440
G
Tnc
tenascin C
severity
IEP
RGD
PMID:20816680
RGD:4889598
NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:77,375,851...77,460,624
G
Tnfaip3
TNF alpha induced protein 3
severity
ISO
protein:increased expression:bile duct (human)
RGD
PMID:26485275
RGD:11250478
NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:13,709,206...13,725,282
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16818635 PMID:22561520
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Ttr
transthyretin
ISO
protein:decreased expression:blood serum (human)
RGD
PMID:18275060
RGD:151660506
NCBI chr18:12,216,684...12,225,972
Ensembl chr18:11,943,789...11,951,008
G
Ugt1a9
UDP glucuronosyltransferase family 1 member A9
ISO
RGD
PMID:9230212
RGD:2325161
NCBI chr 9:96,144,786...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Vegfa
vascular endothelial growth factor A
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:18550579
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Wdhd1
WD repeat and HMG-box DNA binding protein 1
ameliorates
ISO
RGD
PMID:30314946
RGD:156420141
NCBI chr15:22,957,492...23,002,820
Ensembl chr15:20,489,291...20,523,096
G
Wnt9a
Wnt family member 9A
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr10:44,593,691...44,620,682
Ensembl chr10:44,094,140...44,121,133
G
Bap1
BRCA1 associated deubiquitinase 1
disease_progression
ISO
RGD
PMID:25536104
RGD:150340631
NCBI chr16:6,453,126...6,461,952
Ensembl chr16:6,446,709...6,455,535
G
Pbrm1
polybromo 1
disease_progression
ISO
RGD
PMID:25536104
RGD:150340631
NCBI chr16:6,213,507...6,312,895
Ensembl chr16:6,213,300...6,311,780
G
Rac1
Rac family small GTPase 1
ISO
protein:increased expression:mucosa (human)
RGD
PMID:21537609
RGD:153350126
NCBI chr12:16,150,411...16,170,864
Ensembl chr12:11,036,698...11,057,251
G
Slc7a5
solute carrier family 7 member 5
disease_progression
ISO
RGD
PMID:24890221
RGD:151361210
NCBI chr19:66,843,808...66,872,412
Ensembl chr19:49,935,220...49,963,823
G
Pkd1
polycystin 1, transient receptor potential channel interacting
ISO
ClinVar Annotator: match by term: Extrahepatic bile duct cancer
ClinVar
PMID:25741868
NCBI chr10:14,077,733...14,125,682
Ensembl chr10:13,573,021...13,621,128
G
Pold1
DNA polymerase delta 1, catalytic subunit
ISO
ClinVar Annotator: match by term: Extrahepatic bile duct cancer
ClinVar
PMID:25741868 PMID:26467025 PMID:28492532
NCBI chr 1:104,161,984...104,178,074
Ensembl chr 1:95,025,499...95,036,465
G
Xpo1
exportin 1
disease_progression
ISO
protein:increased expression:extrahepatic bile duct (human)
RGD
PMID:27279267
RGD:151665800
NCBI chr14:101,434,450...101,476,705
Ensembl chr14:97,233,270...97,275,498
G
Ace
angiotensin I converting enzyme
ISO
DNA:polymorphism: :rs4646994 (human)
RGD
PMID:20438364
RGD:2325207
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Cdk1
cyclin-dependent kinase 1
ISO
protein:increased expression:gallbladder
RGD
PMID:15017593
RGD:2722465
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408
G
Ddr2
discoidin domain receptor tyrosine kinase 2
disease_progression
ISO
RGD
PMID:29043607
RGD:150429712
NCBI chr13:84,726,412...84,851,032
Ensembl chr13:82,195,463...82,317,363
G
Ifitm1
interferon induced transmembrane protein 1
disease_progression
ISO
RGD
PMID:29043607
RGD:150429712
NCBI chr 1:205,496,757...205,498,796
Ensembl chr 1:196,067,963...196,069,169
G
Apc
APC regulator of WNT signaling pathway
disease_progression
ISO
DNA:SNP::rs11954856(human)
RGD
PMID:26715268
RGD:151356500
NCBI chr18:26,138,382...26,196,021
Ensembl chr18:25,864,222...25,922,696
G
Apob
apolipoprotein B
susceptibility
ISO
DNA:SNP: :rs693 (human)
RGD
PMID:20082485 PMID:17696941
RGD:2325761 , RGD:2325764
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:30,844,368...30,892,497
G
Apoe
apolipoprotein E
susceptibility
ISO
DNA:SNP:intron:rs440446 (human)
RGD
PMID:18296645
RGD:2317550
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
Axin2
axin 2
disease_progression
ISO
DNA:SNP::s4791171(human)
RGD
PMID:26715268
RGD:151356500
NCBI chr10:94,393,379...94,426,579
Ensembl chr10:93,899,245...93,926,231
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
NCBI chr 4:69,329,772...69,476,931
Ensembl chr 4:68,384,649...68,510,463
G
Bub1b
BUB1 mitotic checkpoint serine/threonine kinase B
ISO
mRNA:increased expression:gallbladder
RGD
PMID:18497548
RGD:2324871
NCBI chr 3:126,017,019...126,069,470
Ensembl chr 3:105,563,138...105,615,547
G
Calr
calreticulin
exacerbates
ISO
mRNA, protein:increased expression:gall bladder (human)
RGD
PMID:33591948
RGD:150521682
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:23,308,351...23,313,414
G
Ccr5
C-C motif chemokine receptor 5
onset
ISO
DNA:frameshift mutation:cds:p.S185_T195del rs333 (human)
RGD
PMID:18405329
RGD:2317570
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:123,752,325...123,759,260
G
Ctnnb1
catenin beta 1
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
PMID:10435629 PMID:26822237
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
susceptibility
ISO
DNA:transition:5' utr:-34T>C rs743572 (human)
RGD
PMID:16381022
RGD:2317619
NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:245,535,462...245,541,573
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
DNA:transition: :6235T>C (human) DNA:polymorphism: :p.I462V (human)
RGD
PMID:18287863 PMID:18990008
RGD:2317212 , RGD:2317211
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Dpyd
dihydropyrimidine dehydrogenase
disease_progression
ISO
RGD
PMID:16619549
RGD:2317631
NCBI chr 2:209,293,902...210,159,777
Ensembl chr 2:206,609,122...207,474,982
G
Egf
epidermal growth factor
susceptibility
ISO
DNA:SNP: :+61A>G (rs4444903)(human)
RGD
PMID:8093356 PMID:18571008
RGD:2317646 , RGD:2317641
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:218,219,415...218,302,064
G
Gli1
GLI family zinc finger 1
disease_progression
ISO
DNA:SNP::rs2228226(human)
RGD
PMID:26715268
RGD:151356500
NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:63,156,926...63,169,251
G
Gstm1
glutathione S-transferase mu 1
ISO
RGD
PMID:26925680
RGD:14700928
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
exacerbates
ISO
protein:increased expression:gall bladder (human)
RGD
PMID:26318166
RGD:11528126
NCBI chr19:40,081,126...40,082,910
Ensembl chr19:23,176,294...23,178,035
G
Keap1
Kelch-like ECH-associated protein 1
ISO
DNA:missense mutations, frameshift mutations:cds:multiple (human)
RGD
PMID:18692501
RGD:6893398
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862
G
Kras
KRAS proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
PMID:6320174 PMID:11745231 PMID:15696205 PMID:16051643 PMID:17704260 PMID:25741868 PMID:26242988 PMID:28492532 PMID:31666701 PMID:35658005 More...
NCBI chr 4:179,916,255...179,949,613
G
Lrp1b
LDL receptor related protein 1B
ameliorates
ISO
DNA:mutations:multiple: (human)
RGD
PMID:32898339
RGD:150429787
NCBI chr 3:24,594,302...26,715,037
Ensembl chr 3:24,594,991...26,715,505
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
PMID:15520168 PMID:15608678 PMID:15930273 PMID:17673550 PMID:21078999 PMID:22658544 PMID:22729223 PMID:22729224 PMID:23946963 PMID:25599672 PMID:25741868 PMID:25880439 PMID:26627007 PMID:26637981 PMID:27631024 PMID:28151489 PMID:28425981 PMID:29661094 PMID:30376034 PMID:30543347 PMID:31536475 PMID:37712948 More...
NCBI chr 2:117,103,643...117,177,411
Ensembl chr 2:115,174,984...115,249,032
G
Rbp4
retinol binding protein 4
disease_progression
ISO
associated with type 2 diabetes mellitus; protein:decreased expression:blood serum (human)
RGD
PMID:37273108
RGD:329849105
NCBI chr 1:245,306,349...245,313,551
Ensembl chr 1:235,893,917...235,901,399
G
Rictor
RPTOR independent companion of MTOR, complex 2
ISO
DNA:CNV, amplification:exon (human)
RGD
PMID:24508317
RGD:152995522
NCBI chr 2:57,539,279...57,631,291
Ensembl chr 2:55,811,322...55,901,426
G
Smad4
SMAD family member 4
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
PMID:10479724 PMID:10764709 PMID:16152648 PMID:16436638 PMID:21465659 PMID:22810475 PMID:23239472 PMID:25931195 PMID:26467025 PMID:26689913 PMID:28492532 PMID:30851333 PMID:31949278 PMID:32561076 PMID:32719554 PMID:34393517 PMID:35982159 PMID:36158166 PMID:36451132 PMID:37319387 More...
NCBI chr18:69,518,988...69,549,684
Ensembl chr18:67,243,742...67,274,438
G
Tp53
tumor protein p53
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
PMID:1631137 PMID:1978757 PMID:7478555 PMID:7791795 PMID:8023157 PMID:8062826 PMID:8099841 PMID:8276238 PMID:8425176 PMID:8527048 PMID:8688334 PMID:9150393 PMID:9242456 PMID:9598730 PMID:9825943 PMID:10089074 PMID:11051239 PMID:11370630 PMID:11782540 PMID:11793474 PMID:12406399 PMID:12506399 PMID:12826609 PMID:14673037 PMID:14743206 PMID:15925506 PMID:15993273 PMID:16199547 PMID:16818505 PMID:16861262 PMID:16969106 PMID:17390010 PMID:17417627 PMID:17427234 PMID:17567834 PMID:17572079 PMID:17606709 PMID:17881637 PMID:18978813 PMID:19378321 PMID:19556618 PMID:19711436 PMID:19714490 PMID:20013323 PMID:20128691 PMID:20182602 PMID:20407015 PMID:20436704 PMID:20522432 PMID:21059199 PMID:21305319 PMID:21343334 PMID:21519010 PMID:21601526 PMID:21665182 PMID:21761402 PMID:22186996 PMID:22265402 PMID:22713868 PMID:22915647 PMID:22955915 PMID:23172776 PMID:23246812 PMID:23667202 PMID:23894400 PMID:23950206 PMID:24033266 PMID:24038938 PMID:24382691 PMID:24573247 PMID:24603336 PMID:24651015 PMID:25157968 PMID:25293557 PMID:25544776 PMID:25587027 PMID:25741868 PMID:25925845 PMID:25952993 PMID:26230955 PMID:26425688 PMID:26467025 PMID:26585234 PMID:26619011 PMID:26718964 PMID:26787237 PMID:26911350 PMID:27276561 PMID:27374712 PMID:27463065 PMID:27680515 PMID:27895058 PMID:27959731 PMID:28160093 PMID:28369373 PMID:28472496 PMID:28492532 PMID:28724667 PMID:28861920 PMID:28975465 PMID:29025599 PMID:29324801 PMID:29752822 PMID:29979965 PMID:30224644 PMID:30322717 PMID:30327374 PMID:30720243 PMID:31105275 PMID:31127191 PMID:31742824 PMID:31775759 PMID:32187361 PMID:32817165 PMID:33300245 PMID:33471991 PMID:34240179 PMID:36988593 More...
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Xrcc1
X-ray repair cross complementing 1
susceptibility
ISO
DNA:polymorphisms: :p.R194W, p.R399Q (human)
RGD
PMID:19266243
RGD:2317128
NCBI chr 1:89,268,721...89,296,619
Ensembl chr 1:80,141,207...80,168,701
G
Abo
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
ISO
RGD
PMID:7795450
RGD:2317512
NCBI chr 3:30,560,172...30,604,758
Ensembl chr 3:10,162,096...10,191,423
G
Actr3
actin related protein 3
severity
ISO
Squamous Cell/Adenosquamous Carcinoma and Adenocarcinoma;protein:increased expression:gall bladder (human)
RGD
PMID:23320827
RGD:11571623
NCBI chr13:39,353,413...39,396,509
Ensembl chr13:36,800,093...36,844,124
G
Antxr1
ANTXR cell adhesion molecule 1
severity
ISO
RGD
PMID:21545221
RGD:9684943
NCBI chr 4:121,148,102...121,335,549
Ensembl chr 4:119,590,771...119,778,232
G
Birc3
baculoviral IAP repeat-containing 3
exacerbates
ISO
mRNA:increased expression:gall bladder (human)
RGD
PMID:28295868
RGD:153297817
NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:5,000,845...5,015,802
G
Cfl1
cofilin 1
severity
ISO
Squamous Cell/Adenosquamous Carcinoma and Adenocarcinoma;protein:increased expression:gall bladder (human)
RGD
PMID:23320827
RGD:11571623
NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:202,786,627...202,817,587
G
Clptm1l
CLPTM1-like
susceptibility
ISO
DNA:SNP, haplotype: :rs401681(human)
RGD
PMID:29450669
RGD:150530629
NCBI chr 1:31,496,094...31,512,148
Ensembl chr 1:29,667,545...29,683,530
G
Gpx3
glutathione peroxidase 3
severity
ISO
protein:decreased expression:gallbladder (human)
RGD
PMID:24167362
RGD:151665515
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
G
Il10
interleukin 10
susceptibility
ISO
associated with Cholelithiasis
RGD
PMID:19065724
RGD:2317654
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Mir155
microRNA 155
disease_progression
ISO
miRNA:increased expression:gall bladder
RGD
PMID:26885061
RGD:21079444
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:23,774,654...23,774,718
G
Mtus1
microtubule associated scaffold protein 1
disease_progression
ISO
RGD
PMID:31882471
RGD:25330344
NCBI chr16:57,905,991...58,051,466
Ensembl chr16:51,253,562...51,347,793
G
Ptch1
patched 1
disease_progression
ISO
RGD
PMID:22407314
RGD:150523794
NCBI chr17:1,548,449...1,613,461
Ensembl chr17:1,542,877...1,607,333
G
Rac1
Rac family small GTPase 1
exacerbates
ISO
protein:increased expression:gallbladder (human)
RGD
PMID:21853342
RGD:155230819
NCBI chr12:16,150,411...16,170,864
Ensembl chr12:11,036,698...11,057,251
G
Tert
telomerase reverse transcriptase
susceptibility
ISO
DNA:SNP, haplotype: :rs2736100(human)
RGD
PMID:29450669
RGD:150530629
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:29,637,506...29,659,561
G
Tgfa
transforming growth factor alpha
ISO
RGD
PMID:9542514
RGD:2317470
NCBI chr 4:120,175,549...120,258,342
Ensembl chr 4:118,618,269...118,700,894
G
Tjp1
tight junction protein 1
ISO
protein:decreased expression:gallbladder
RGD
PMID:19184677
RGD:2325030
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:118,849,838...119,094,432
G
Tymp
thymidine phosphorylase
disease_progression
ISO
RGD
PMID:18946757
RGD:2325157
NCBI chr 7:122,318,396...122,323,716
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
G
Ubr5
ubiquitin protein ligase E3 component n-recognin 5
ameliorates
ISO
human cell line in a mouse model
RGD
PMID:30775814
RGD:151665192
NCBI chr 7:71,000,197...71,109,841
Ensembl chr 7:69,116,761...69,224,903
G
Apc
APC regulator of WNT signaling pathway
ISO
ClinVar Annotator: match by term: Intrahepatic cholangiocarcinoma
ClinVar
PMID:24728327 PMID:25479140 PMID:25741868 PMID:26467025 PMID:26530882 PMID:28135048 PMID:28195569 PMID:28492532 PMID:32390703 More...
NCBI chr18:26,138,382...26,196,021
Ensembl chr18:25,864,222...25,922,696
G
Arid1a
AT-rich interaction domain 1A
disease_progression exacerbates
ISO
mRNA,protein:decreased expression:intrahepatic bile duct (human)
RGD
PMID:30849962 PMID:27433094 PMID:31665232
RGD:14974231 , RGD:126775257 , RGD:126781775
NCBI chr 5:151,192,014...151,269,291
Ensembl chr 5:145,908,181...145,985,564
G
Bap1
BRCA1 associated deubiquitinase 1
disease_progression
ISO
RGD
PMID:27864835
RGD:150340628
NCBI chr16:6,453,126...6,461,952
Ensembl chr16:6,446,709...6,455,535
G
Becn1
beclin 1
disease_progression
ISO
RGD
PMID:30849962
RGD:14974231
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
severity
IAGP
DNA:missense mutation:cds:p.V600E (human)
RGD
PMID:24139215
RGD:14398746
NCBI chr 4:69,329,772...69,476,931
Ensembl chr 4:68,384,649...68,510,463
G
Fas
Fas cell surface death receptor
disease_progression
ISO
RGD
PMID:11003620
RGD:14700701
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
severity
ISO
RGD
PMID:11003620
RGD:14700701
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:74,154,954...74,162,215
G
Foxp3
forkhead box P3
IDA
DNA:hypomethylation:liver
RGD
PMID:24291052
RGD:38599002
NCBI chr X:17,580,380...17,601,181
Ensembl chr X:14,908,494...14,923,838
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
disease_progression
ISO
protein:increased expression:liver (human)
RGD
PMID:24796583
RGD:152177907
NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:129,702,383...129,707,268
G
Hsp90ab1
heat shock protein 90 alpha family class B member 1
disease_progression
ISO
protein:increased expression:liver (human)
RGD
PMID:24796583
RGD:152177907
NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:15,433,691...15,438,488
G
Idh1
isocitrate dehydrogenase (NADP(+)) 1
no_association
ISO
DNA:misssense mutations:cds:p.Arg132Cys,Arg132Leu (human)
RGD
PMID:26245674
RGD:14974229
NCBI chr 9:74,027,887...74,057,442
Ensembl chr 9:66,534,146...66,563,708
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
disease_progression
ISO
DNA:mutations: : mRNA:decreased expression:liver (mouse)
RGD
PMID:22824796 PMID:32463951
RGD:14985256 , RGD:149735894
NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:134,029,772...134,058,025
G
Kdm5c
lysine demethylase 5C
exacerbates
ISO
protein:decreased expression:bile duct (human)
RGD
PMID:32714863
RGD:151361175
NCBI chr X:21,345,459...21,387,045
Ensembl chr X:21,345,481...21,381,870
G
Kras
KRAS proto-oncogene, GTPase
disease_progression
ISS ISO
DNA:mutations::
MouseDO RGD
PMID:24139215
RGD:14398746
NCBI chr 4:179,916,255...179,949,613
G
Lcn2
lipocalin 2
treatment
IDA ISO
Protein:increased expression:bile duct
RGD
PMID:24939880 PMID:24939880
RGD:126790491 , RGD:126790491
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:15,680,687...15,684,095
G
Lrp1b
LDL receptor related protein 1B
exacerbates
ISO
DNA:mutations:multiple: (human)
RGD
PMID:33014052
RGD:150429786
NCBI chr 3:24,594,302...26,715,037
Ensembl chr 3:24,594,991...26,715,505
G
Magi1
membrane associated guanylate kinase, WW and PDZ domain containing 1
disease_progression
ISO
protein:increased expression:intrahepatic bile duct (human)
RGD
PMID:30377796
RGD:152998946
NCBI chr 4:127,762,590...128,368,228
Ensembl chr 4:126,206,816...126,811,691
G
Mir152
microRNA 152
ISO
miRNA:decreased expression:intrahepatic bile duct
RGD
PMID:28921383
RGD:19165148
NCBI chr10:82,329,383...82,329,467
Ensembl chr10:81,832,936...81,833,020
G
Mir200b
microRNA 200b
ISO
RNA:increased expression:liver
RGD
PMID:27685844
RGD:14928335
NCBI chr 5:171,931,495...171,931,589
Ensembl chr 5:166,649,272...166,649,366
G
Mir21
microRNA 21
ISO
RNA:increased expression:liver,plasma
RGD
PMID:27685844
RGD:14928335
NCBI chr10:71,902,600...71,902,691
Ensembl chr10:71,405,257...71,405,348
G
Mir221
microRNA 221
severity
ISO
RGD
PMID:27685844
RGD:14928335
NCBI chr X:6,023,182...6,023,290
Ensembl chr X:3,429,465...3,429,573
G
Pbrm1
polybromo 1
disease_progression
ISO
protein:increased expression:intrahepatic bile duct (human)
RGD
PMID:30377796 PMID:27864835
RGD:152998946 , RGD:150340628
NCBI chr16:6,213,507...6,312,895
Ensembl chr16:6,213,300...6,311,780
G
Pten
phosphatase and tensin homolog
disease_progression
ISO
protein:decreased expression:liver (human)
RGD
PMID:24796583
RGD:152177907
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:230,630,338...230,696,838
G
Rnf43
ring finger protein 43
exacerbates
ISO
mRNA, protein:decreased expression:liver, bile duct epithelium (human)
RGD
PMID:26980022
RGD:151361125
NCBI chr10:72,958,744...73,034,540
Ensembl chr10:72,464,348...72,536,977
G
Runx1
RUNX family transcription factor 1
ISO
mRNA:increased expression:intrahepatic bile duct
RGD
PMID:31015363
RGD:126775143
NCBI chr11:45,325,778...45,560,300
Ensembl chr11:31,843,764...32,074,542
G
S100b
S100 calcium binding protein B
disease_progression
ISO
protein:increased expression:intrahepatic bile duct (human)
RGD
PMID:30377796
RGD:152998946
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,881...12,394,743
G
Smad4
SMAD family member 4
disease_progression
ISO
mRNA,protein:decreased expression:intrahepatic bile duct
RGD
PMID:16917866 PMID:23981608
RGD:18936999 , RGD:21066336
NCBI chr18:69,518,988...69,549,684
Ensembl chr18:67,243,742...67,274,438
G
Tep1
telomerase associated protein 1
ISO
mRNA:increased expression:hepatocyte,biliary epithelium.
RGD
PMID:10498642
RGD:152977753
NCBI chr15:26,519,429...26,567,073
Ensembl chr15:24,045,878...24,093,526
G
Terc
telomerase RNA component
ISO
RNA:increased expression:hepatocyte,biliary epithelium.
RGD
PMID:10498642
RGD:152977753
NCBI chr 2:114,744,148...114,744,535
G
Apc
APC regulator of WNT signaling pathway
ISO
ClinVar Annotator: match by term: Klatskin tumor
ClinVar
PMID:25741868 PMID:28492532
NCBI chr18:26,138,382...26,196,021
Ensembl chr18:25,864,222...25,922,696
G
Arid1a
AT-rich interaction domain 1A
disease_progression
ISO
DNA:deletions
RGD
PMID:33387086
RGD:126848756
NCBI chr 5:151,192,014...151,269,291
Ensembl chr 5:145,908,181...145,985,564
G
Gata6
GATA binding protein 6
sexual_dimorphism
ISO
DNA:mutations
RGD
PMID:33387086
RGD:126848756
NCBI chr18:2,460,909...2,492,322
Ensembl chr18:2,188,121...2,219,532
G
Kmt2c
lysine methyltransferase 2C
onset
ISO
DNA:mutations
RGD
PMID:33387086
RGD:126848756
NCBI chr 4:10,353,698...10,755,965
Ensembl chr 4:9,609,627...9,833,539
G
Kras
KRAS proto-oncogene, GTPase
disease_progression
ISO
DNA:mutations
RGD
PMID:33387086
RGD:126848756
NCBI chr 4:179,916,255...179,949,613
G
Prex2
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2
sexual_dimorphism
ISO
DNA:substitutions, insertion/deletions: (human)
RGD
PMID:33387086 PMID:33387086
RGD:126848756 , RGD:126848756
NCBI chr 5:12,720,683...13,036,077
Ensembl chr 5:7,942,573...8,253,068
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all